What Is Cancer?
The Dimension of the Cancer Epidemic
At the beginning of the 21st Century, cancer remains one of the largest epidemics of mankind. It is almost impossible to demonstrate the entire magnitude of this epidemic. What we can do to visualize its dimension is to take the number of cancer patients who die each year – and compare it to the population of the world’s largest cities.
Every year the cancer epidemic takes the lives of 7. 5 million patients worldwide. In comparison, here are the current population numbers for some of the world’s largest metropoles: Tokyo 8.9 million, Mexico City 8.9 million, New York City 8.4 million, Lagos (Nigeria) 8 million, London 7. 8 million, Lima (Peru) 7.6 million, Hong Kong 7 million, Bangkok (Thailand) 7 million, Cairo (Egypt) 6. 8 million and Rio de Janeiro (Brazil) 6. 3 million.
Imagine you are living in one of these giant cities. You have to drive for hours to get from one end of the city to the other. And all those people living in every street of this city disappear each year as the result of this unconquered epidemic.
Over the past half century more than 300 million people have died from cancer – this translates to the eradication of the entire population of the United States of America. Besides the unimaginable cost of human life there is a strangulating economic burden associated with this disease for every patient, community and country.
The global costs for oncology drugs in 2010 alone was 56 billion US dollars. The economic impact of the cancer epidemic – excluding all medical costs – was even more staggering: With 895 billion US dollars, cancer had by far the greatest economic toll among all diseases.
The Deadlocks of 'Chemotherapy'
Before addressing new approaches, we have to understand why conventional cancer therapies were unable to win the 'War on Cancer':
- Over the past half century, the cancer epidemic has been turned into the single largest market for patented pharmaceutical drugs.
- The widespread use of highly toxic chemicals as so-called 'chemotherapy' has given rise to a myriad of 'side effect diseases' including anemia, inflammation, organ damage – each of which represents another multi-billion dollar drug market.
- To protect these giant global markets, the special interests behind the investment 'business with cancer' have built a 'smoke screen' of research. While addressing these 'mosaics' of specific cancer types they consistently neglected the 'big picture', the mechanism common to all types of cancer: collagen digestion as the precondition for invasive spread and metastasis.
- Considering the fact that over 90% of all cancer deaths occur during cancer metastasis, this negligence affects the health and lives of millions and is no longer acceptable.
More details can be found in Dr. Rath’s and Dr. Niedzwiecki’s new book. You can read this book online here.